Ignite Creation Date:
2025-12-25 @ 4:50 AM
Ignite Modification Date:
2025-12-26 @ 3:52 AM
Study NCT ID:
NCT03485118
Status:
COMPLETED
Last Update Posted:
2018-04-02
First Post:
2018-03-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
RHCACD20MA (HS006) Combined With CHOP (Hi-CHOP) in Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Sponsor:
Zhejiang Hisun Pharmaceutical Co. Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-12
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-03-26
First Submit QC Date:
None
Study First Post Date:
2018-04-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-30
Last Update Post Date:
2018-04-02
Last Update Post Date Type:
ACTUAL